Vaccines

20 Jun 2016 Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial
20 Jun 2016 Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months
18 Jun 2016 SCIB1 Drug Product Supply
17 Jun 2016 FDA Accepts Emergent BioSolutions’ Supplemental Biologics License Application for Large-Scale Manufacturing of BioThrax in Building 55
11 Jun 2016 FDA Approves Vaxchora, PaxVax’s Single-Dose Oral Cholera Vaccine
08 Jun 2016 Immune Design Releases New PFS, OS and TME Data from Trials of Three Immuno-Oncology Product Candidates
07 Jun 2016 ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma
07 Jun 2016 Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016
07 Jun 2016 VAXIMM Presents Data from Phase I Trial in Pancreatic Cancer with Oral T-cell Immunotherapy VXM01 at ASCO 2016 Annual Meeting
05 Jun 2016 OBI Pharma Presents Data For Novel Investigational OBI-822/OBI-821 In Patients With Metastatic Breast Cancer At The 2016 American Society Of Clinical Oncology Annual Meeting
02 Jun 2016 Valneva´s Pseudomonas Aeruginosa Candidate (VLA43) Did Not Confirm Positive Vaccine Effect in Phase II/III trial
02 Jun 2016 Targovax receives approval in Australia to conduct a clinical trial with TG02 - an immunotheraphy treatment targeting RAS mutations
25 May 2016 ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease
24 May 2016 Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
24 May 2016 Bavarian Nordic Announces Positive Top Line Results from a Phase 1 Trial of a Novel, Broad Spectrum RSV Vaccine in Healthy Adult and Elderly Populations
21 May 2016 Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)
16 May 2016 This Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses in Non-Human Primates
14 May 2016 Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting
14 May 2016 NeOnc Technologies Announces Initiation of Phase 1/2a Clinical Trial of NEO100™ in Recurrent Glioblastoma Multiforme (GBM)
12 May 2016 OncBioMune Provides Update on Phase 2 Clinical Trials of ProscaVax for Prostate Cancer
11 May 2016 NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic Cancer
10 May 2016 Dr. Patrick Soon-Shiong Presents Promising Results of Novel Adenoviral Colon Cancer Vaccine in Treating End-Stage Colon Cancer at the Bank of America Merrill Lynch 2016 Health Care Conference
09 May 2016 Allergy Therapeutics announces positive top-line results from the PQBirch204 Phase II study for birch-induced seasonal allergic rhinitis
04 May 2016 SELLAS Life Sciences Announces Positive WT1 Cancer Vaccine (galinpepimut-S) Clinical Results at the 13th International Conference of the International Mesothelioma Interest Group (iMig)
04 May 2016 VAXIMM initiates Phase 2a study in advanced colorectal cancer with oral T-cell vaccine VXM01

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top